Boswellia 125 mg
Natural health product licensed in Canada
- Licence holder
- Natural Factors Nutritional Products Limited
- NPN or DIN-HM
- 80102002
- Status
- Active licence
- Licence date
- 19 June 2020
- Revision date
- 30 April 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Boswellia serrata Source : Gum oleoresin Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,250 mg Potency : 30 % 3-Acetyl-11-keto-beta-boswellic acid | 125 mg | Not calculated |
Non-medicinal ingredients
Croscarmellose de sodium, Stéarate de magnésium, Silice, Acide stéarique, NA, Eau purifiée, farine de riz
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Helps reduce pain and stiffness associated with osteoarthritis of the knee. Helps to relieve pain associated with osteoarthritis of the knee. Helps to reduce joint pain associated with osteoarthritis of the knee. Helps to relieve joint pain and stiffness associated with osteoarthritis of the knee. Starts to help reduce joint pain and stiffness due to osteoarthritis of the knee in as little as 7 days. Supportive therapy for joint pain associated with osteoarthritis of the knee. May help reduce joint pain associated with osteoarthritis of the knee through supporting healthy inflammatory response. Helps to improve joint Function by reducing joint pain in patients with Osteoarthritis of the knee.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a physician prior to use if you are pregnant or breastfeeding. Consult your physician if symptoms persist or worsen. Hypersensitivity (e.g. allergy) has been known to occur; in which case discontinue use. Some people may experience mild gastrointestinal effects such as diarrhea, abdominal pain/cramps and nausea. Keep out of reach of children .
Source
Official Health Canada record, licence 80102002
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging